Interní Med. 2013; 15(1): 15-18

Osteoporosis in men

MUDr.Jiří Jenšovský, CSc.
Interní klinika Ústřední vojenské nemocnice &ndash, Vojenské fakultní nemocnice Praha a I. LF UK Praha, Osteocentrum

Osteoporosis in men is a condition with an ever-increasing incidence. In spite of numerous specific features of the male skeleton and

its development throughout life, both the diagnostic and therapeutic criteria are derived from the approach to osteoporosis in women.

Men with proximal femoral fracture have a very significantly worse prognosis than women in this clinical situation. In men, it is always

necessary to very carefully search for possible secondary causes of the disease. In therapeutic terms, data and approval for the treatment

of male osteoporosis are available for substantially fewer products than in the case of osteoporosis in women. Most recently, since this

year, the use of strontium ranelate has been approved for the treatment of osteoporosis in men.

Keywords: osteoporosis in men, diagnosis, treatment

Published: January 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jenšovský J. Osteoporosis in men. Interní Med. 2013;15(1):15-18.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low trauma fracture in men and women. J Am Med Assoc, 2007; 297: 387-394. Go to original source... Go to PubMed...
    2. Nguyen ND, Ahlborg HG, Center JR, et al. Residual lifetime risk of fractures in women and in men. J Bone Miner Res, 2007; 22: 781-788. Go to original source... Go to PubMed...
    3. Hu R, Mustard CA, Burns C. Epidemiology of incident spinal fracture in a complete population. Spine, 1996; 21: 492-499. Go to original source... Go to PubMed...
    4. Nguyen TV, Center JR, Sambrook PN, et al. Risk factors for proximal humerus, forearm and wrist fractures in elderly men and women: the Dubbo Osteoporosis Epidemiology Study. Am J Epidemiol, 2001; 153: 587-595. Go to original source... Go to PubMed...
    5. Forsen L, Sogaard AJ, Meyer HE, et al. Survival after hip fracture: short and long term excess mortality according to age and gender. Osteoporos Int, 1999; 10: 73-78. Go to original source... Go to PubMed...
    6. Schurch MA, Rizzoli R, Mermillod B, et al. A prospective study on socio-economic aspects of fracture of proximal femur. J Bone Miner Res, 1996; 11: 1935-1942. Go to original source... Go to PubMed...
    7. Felsenberg D, Silman AJ, Lunt M, et al. Incidence of vertebral fracture in Europe: results from EPOS Study. J Bone Miner Res, 2002; 17: 716-724. Go to original source... Go to PubMed...
    8. Mallmin H, Ljunghall S, Persson I, et al. Fracture of the distal forearm as a forecaster of a subsequent hip fracture. Calcif Tissue Int, 1993; 52: 269-272. Go to original source... Go to PubMed...
    9. Kanis JA, Johnell O, Oden A, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int, 2008, DOI 10 1007/s00198-007-0543-5, in press, available online. Go to original source... Go to PubMed...
    10. Mellstrom D, Vandenput L, Mallmin H, et al. Older men wit low serum estradioland high serum SHBG have an increased risk of fractures. J Bone Miner Res, 2008; 23: 1552-1560. Go to original source... Go to PubMed...
    11. Orwoll E, Lambert LC, Marshall LM, et al. Group OFiMS, Testosterone and estradiol among older men. J Clin Endocrinol Metab, 2006; 91: 1336-1344. Go to original source... Go to PubMed...
    12. Holick MF: Vitamin D deficiency. NEJM, 2007; 357: 266-281. Go to original source... Go to PubMed...
    13. Cannell J, Hollis B, Zasloff M, et al. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother, 2008; 9: 107-108. Go to original source... Go to PubMed...
    14. NIH: NIH Consensus statement (No4 edn), Bethesda 1994.
    15. Behre HM, Kliesch S, Leifke E, et al. Long term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab, 1997; 82: 2386-2390. Go to original source... Go to PubMed...
    16. Snyder PJ, Peachey H, Hannousch P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab, 1999; 84: 1966-1972. Go to original source...
    17. Orwoll E, Ettinger M, Weiss, et al. Alendronate for the treatment of osteoporosisi in men. NEJM, 2000; 343: 604-610. Go to original source... Go to PubMed...
    18. Boonen S, Delmas P, Wenderoth D, et al. Risedronate safe and effective in men with osteoporosis. Osteoporos Int, 2006; 17: S106-S107.
    19. Orwoll E, Scheele WH, Paul S, et al. The effect of teriparatide therapy on bone density in men with osteoporosis. J Bone Miner Res, 2003; 18: 9-17. Go to original source... Go to PubMed...
    20. Collette J, Reginster J-Y. Strontium ranelate uncouples bone formation from bone resorption in male osteoporotic patients.
    21. Kaufman JM, Audran M, Bianchi G, et al. Efficacy and safety of strontium ranelate in the treatment of male osteoporosis. Osteoporos Int, 2012; 23(Suppl. 2): S260. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.